Literature DB >> 14047076

[PROPERTIES OF ADENOVIRUS HEMAGGLUTININS].

H BAUER, R WIGAND.   

Abstract

Keywords:  ADENOVIRUS; ANTIBODIES; ERYTHROCYTES; EXPERIMENTAL LAB STUDY; HEAT; HEMAGGLUTINATION; MONKEYS; RATS; TRYPSIN

Mesh：

Substances：

Year:  1963        PMID： 14047076

Source DB:  PubMed          Journal:  Z Hyg Infektionskr        ISSN： 0340-1782


× No keyword cloud information.
  17 in total

1.  Correlation between the surface structure of viruses and latency.

Authors:  V M ZHDANOV; L B MEKLER
Journal:  Nature       Date:  1962-09-01       Impact factor: 49.962

2.  Study of adenovirus antigens by immunoelectrophoresis.

Authors:  H G PEREIRA; A C ALLISON; C P FARTHING
Journal:  Nature       Date:  1959-03-28       Impact factor: 49.962

3.  Chromatography of adenoviruses on calcium phosphate columns.

Authors:  M SIMON
Journal:  Acta Virol       Date:  1962-07       Impact factor: 1.162

4.  Haemagglutination experiments with certain adenovirus type strains.

Authors:  M SIMON
Journal:  Acta Microbiol Acad Sci Hung       Date:  1962

5.  Heterogeneity of adenovirus hemagglutinins. (Brief report).

Authors:  H BAUER; R WIGAND
Journal:  Arch Gesamte Virusforsch       Date:  1962

6.  Four newly recognized adenoviruses.

Authors:  L ROSEN; S BARON; J A BELL
Journal:  Proc Soc Exp Biol Med       Date:  1961-06

7.  A virus inhibitor produced in HeLa cells infected with adenovirus.

Authors:  H G PEREIRA
Journal:  Virology       Date:  1960-07       Impact factor: 3.616

8.  Modification of erythrocyte receptors by a factor in adenovirus suspensions.

Authors:  J A KASEL; W P ROWE; J L NEMES
Journal:  Virology       Date:  1960-03       Impact factor: 3.616

9.  Serotype composition of the adenovirus group.

Authors:  W P ROWE; J W HARTLEY; R J HUEBNER
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

10.  Informative studies on the haemagglutination spectra of adenoviruses.

Authors:  I NASZ; A LENGYEL; P DAN; G KULCSAR
Journal:  Acta Microbiol Acad Sci Hung       Date:  1962
View more
  17 in total

1.  [ON THE CYTOPATHOGENIC EFFECT OF ADENOVIRUSES IN MAN].

Authors:  R WIGAND; H BAUER
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

2.  [SELECTIVE INACTIVATION OF ADENOVIRUS HEMAGGLUTININS. (SHORT REPORT)].

Authors:  H BAUER
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS.

Authors:  R WIGAND; H BAUER; F LANG; W ADAM
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber.

Authors:  B Eiz; P Pring-Akerblom
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  [Isolation and differeniation of adenovirus type 8 in epidemic keratoconjunctivitis in Leipzig].

Authors:  M Marré; W Rohde; G Kler
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1967

6.  Neutralization of adenovirus toxins: specificity and antigenic relationships.

Authors:  N Döring; C X Nguyen; R Wigand
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

7.  [Serologically intermediary adenovirus strains].

Authors:  R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1965

8.  Separation and characterization of soluble adenovirus type 9 components.

Authors:  E Norrby; B Nyberg; P Skaaret; A Lengyel
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

9.  [The inactivation of adenovirus components by means of physical and chemical agents].

Authors:  N Ratanakrong; R Wigand
Journal:  Z Med Mikrobiol Immunol       Date:  1968

10.  The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution.

Authors:  Elena Seiradake; Daniel Henaff; Harald Wodrich; Olivier Billet; Matthieu Perreau; Claire Hippert; Franck Mennechet; Guy Schoehn; Hugues Lortat-Jacob; Hanna Dreja; Sandy Ibanes; Vasiliki Kalatzis; Jennifer P Wang; Robert W Finberg; Stephen Cusack; Eric J Kremer
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.